Therapy Areas
2 April 2026 - Caliway Biopharmaceuticals (TWSE:6919), a Taiwan-based clinical-stage biopharmaceutical company, announced on Thursday that the latest preclinical data on its first-in-class large-area localised fat reduction drug candidate, CBL-514, i...
2 April 2026 - Denver-based Mary's Medicinals, a subsidiary of MM Brands Inc, announced on Wednesday its intent to participate in the newly established Centers for Medicare & Medicaid Services (CMS) cannabinoid therapy trial programme.Launch...
2 April 2026 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity, or overweight with weight-related medical probl...
1 April 2026 - Thermo Fisher Scientific Inc (NYSE: TMO) announced on Wednesday that it has unveiled its next-generation Gibco CHOvantage GS Cell Line Development (CLD) Kit, an integrated platform designed to accelerate biologics development while sup...
1 April 2026 - Medical device company QT Imaging Holdings Inc (Nasdaq: QTI) announced on Wednesday that it has released version 4.5.0 of its breast imaging reconstruction software, delivering enhanced image quality and performance across complex clin...
1 April 2026 - Technology company Tempus AI Inc (NASDAQ: TEM) and Medtronic on Wednesday announced results from the ALERT trial, demonstrating that AI-driven electronic health record notifications significantly improve the evaluation and treatment of...
1 April 2026 - Veterinary pharmaceutical company Parnell Technologies Pty Ltd on Wednesday announced the US launch of nixiFLOR, an injectable solution approved by the US Food and Drug Administration (FDA) for the treatment of bovine respiratory disea...